Shots: Lotus to get an exclusive commercialization right of biosimilar Darbepoetin alfa in Taiwan and Southeast Asian markets The collaboration allows the Lotus to re-emphasize its focus on nephrology as […]readmore
Tags : Biosimilar Darbepoetin Alfa